Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · IEX Real-Time Price · USD
6.39
+0.05 (0.79%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Fennec Pharmaceuticals Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for FENC stock have an average target of 16, with a low estimate of 15 and a high estimate of 17. The average target predicts an increase of 150.39% from the current stock price of 6.39.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 15, 2024.
Analyst Ratings
The average analyst rating for FENC stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 4 | 1 | 1 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 3 | 3 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $20 → $17 | Strong Buy | Maintains | $20 → $17 | +166.04% | May 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $18 → $15 | Strong Buy | Maintains | $18 → $15 | +134.74% | May 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $17 → $18 | Strong Buy | Maintains | $17 → $18 | +181.69% | Apr 4, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $17 → $18 | Strong Buy | Maintains | $17 → $18 | +181.69% | Mar 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $18 → $17 | Strong Buy | Maintains | $18 → $17 | +166.04% | Aug 4, 2023 |
Financial Forecast
Revenue This Year
64.20M
from 21.25M
Increased by 202.07%
Revenue Next Year
68.55M
from 64.20M
Increased by 6.78%
EPS This Year
0.54
from -0.60
EPS Next Year
0.60
from 0.54
Increased by 12.20%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 88.6M | 85.2M | 120.6M | 156.9M | 202.4M |
| Avg | 64.2M | 68.6M | 96.5M | 125.0M | 162.9M |
| Low | 50.7M | 49.5M | 65.9M | 86.7M | 124.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 316.7% | 32.8% | 75.9% | 62.7% | 61.9% |
| Avg | 202.1% | 6.8% | 40.7% | 29.6% | 30.3% |
| Low | 138.6% | -23.0% | -3.9% | -10.1% | -0.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.17 | 1.40 | 2.70 | 4.01 | 5.42 |
| Avg | 0.54 | 0.60 | 1.81 | 3.60 | 5.26 |
| Low | -0.11 | -0.36 | 0.54 | 3.17 | 5.06 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 160.9% | 349.4% | 121.3% | 50.7% |
| Avg | - | 12.2% | 201.8% | 98.4% | 46.4% |
| Low | - | - | -10.2% | 74.7% | 40.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.